Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Creator
  • McAuley, Alexander J.
    • Other Affiliation: Institute for Human Infections and Immunity; University of Texas Medical Branch
  • Torres, Maricela
    • Other Affiliation: Department of Microbiology and Immunology; University of Texas Medical Branch
  • Plante, Jessica A.
    • Gillings School of Global Public Health
    • Other Affiliation: Department of Pathology; University of Texas Medical Branch
  • Huang, Claire Y.-H.
    • Other Affiliation: Arbovirus Diseases Branch; Division of Vector-Borne Diseases; Centers for Disease Control and Prevention; U.S. Department of Health and Human Services
  • Bente, Dennis A.
    • Other Affiliation: Center for Biodefense and Emerging Infectious Diseases; University of Texas Medical Branch
  • Beasley, David W.C.
    • Other Affiliation: Center for Biodefense and Emerging Infectious Diseases; University of Texas Medical Branch
Abstract
  • ABSTRACT Flaviviruses are positive-sense, single-stranded RNA viruses responsible for millions of human infections annually. The envelope (E) protein of flaviviruses comprises three structural domains, of which domain III (EIII) represents a discrete subunit. The EIII gene sequence typically encodes epitopes recognized by virus-specific, potently neutralizing antibodies, and EIII is believed to play a major role in receptor binding. In order to assess potential interactions between EIII and the remainder of the E protein and to assess the effects of EIII sequence substitutions on the antigenicity, growth, and virulence of a representative flavivirus, chimeric viruses were generated using the West Nile virus (WNV) infectious clone, into which EIIIs from nine flaviviruses with various levels of genetic diversity from WNV were substituted. Of the constructs tested, chimeras containing EIIIs from Koutango virus (KOUV), Japanese encephalitis virus (JEV), St. Louis encephalitis virus (SLEV), and Bagaza virus (BAGV) were successfully recovered. Characterization of the chimeras in vitro and in vivo revealed differences in growth and virulence between the viruses, with in vivo pathogenesis often not being correlated with in vitro growth. Taken together, the data demonstrate that substitutions of EIII can allow the generation of viable chimeric viruses with significantly altered antigenicity and virulence. IMPORTANCE The envelope (E) glycoprotein is the major protein present on the surface of flavivirus virions and is responsible for mediating virus binding and entry into target cells. Several viable West Nile virus (WNV) variants with chimeric E proteins in which the putative receptor-binding domain (EIII) sequences of other mosquito-borne flaviviruses were substituted in place of the WNV EIII were recovered, although the substitution of several more divergent EIII sequences was not tolerated. The differences in virulence and tissue tropism observed with the chimeric viruses indicate a significant role for this sequence in determining the pathogenesis of the virus within the mammalian host. Our studies demonstrate that these chimeras are viable and suggest that such recombinant viruses may be useful for investigation of domain-specific antibody responses and the more extensive definition of the contributions of EIII to the tropism and pathogenesis of WNV or other flaviviruses.
Date of publication
Keyword
DOI
Identifier
Resource type
  • Article
Rights statement
  • In Copyright
Journal title
  • Journal of Virology
Journal volume
  • 90
Journal issue
  • 9
Language
  • English
ISSN
  • 0022-538X
  • 1070-6321
  • 1098-5514

Relations

Parents:

This work has no parents.

Items

Thumbnail Title Date Uploaded Visibility Actions
file details PubMedCentral-PMC4836310.pdf 2016 Public Download